Press release
Colorectal Cancer Market is projected to exhibit a CAGR of 4.7%, with an estimated worth of US$ 2.88 billion by year 2032 end | PMR
๐๐จ๐ฅ๐จ๐ซ๐๐๐ญ๐๐ฅ ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐ค๐๐ญ๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐ญ๐ก๐ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ฅ๐จ๐ซ๐๐๐ญ๐๐ฅ ๐๐๐ง๐๐๐ซ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ญ ๐ ๐๐๐๐ ๐จ๐ ๐.๐๐% ๐๐ฎ๐ซ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐.
Colorectal cancer, also known as colon cancer, is cancer which begins in the alimentary or colon. The bowel and colon have the function of supporting the digestive functioning of the body. As a U-shaped tube made of muscle and found below the stomach, the colon is responsible for absorbing water and some food nutrients. The celiac, which is at the end of your colon and on the other side of the anal canal, is where the body stores stool. Colon cancer arises when there are changes in the genetic material (DNA). Usually, the changes in DNA that can lead to colon cancer happen during the lifetime. Along with genetics, other factors that may contribute to colon cancer are the lifestyle and the environment.
๐๐ฌ๐ค ๐๐ฌ ๐ญ๐จ ๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market/request-for-sample
The common symptoms of colon cancer include blood in the stool, persistent changes in bowel habits, abdominal pain, bloated stomach, and unexplained weight loss. The treatment for colon cancer takes the form of radiation therapy, targeted therapy, chemotherapy, and immunotherapy. Other treatment options include surgery and embolization. The rising prevalence of cancer cases worldwide is one of the primary factors propelling the colorectal cancer market demand.
๐๐๐ฒ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ซ๐ญ๐ข๐๐ข๐ฉ๐๐ง๐ญ๐ฌ
Some of the major players operating in the global market are:
โข Amgen Inc
โข Epigenomics AG
โข Bruker Corporation
โข Clinical Genomics Technologies Pty Ltd.
โข F. Hoffmann-La Roche AG
โข VolitionRx Limited
โข Abbott
โข Novigenix SA
โข Quest Diagnostics
โข EDP Biotech
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/buy/1979/2
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐ฒ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ :
โข Radiation Therapy
โข Targeted therapy
โข Chemotherapy
โข Immunotherapy
โข Surgery
โข Embolization
โข Others
๐๐ฒ ๐๐ง๐-๐๐ฌ๐ :
โข Hospitals
โข Specialty Clinics
โข Diagnostic & Research Laboratories
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ
North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ญ๐๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/global-colorectal-cancer-market
Colorectal Cancer Market Report Highlights
โข Targeted therapy has become prominent due to the crucial life-preserving activities that this section performs
โข Diagnostic & Research Laboratories are anticipated to grow significantly, especially in emerging nations due to the rising affordability of diagnostic technology and tools.
โข North America had the greatest share, and it is expected to continue to lead because of the rising illness burden, rising treatment rates, and expensive prescription prices.
โข The global key market players include F. Hoffmann-La Roche AG, VolitionRx Limited, Abbott, Novigenix SA, Quest Diagnostics, and EDP Biotech.
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ :
๐๐ฒ๐น๐น ๐๐๐ผ๐น๐ฎ๐๐ถ๐ผ๐ป/๐๐ฒ๐น๐น ๐ฆ๐ฒ๐ฝ๐ฎ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ : https://www.polarismarketresearch.com/industry-analysis/global-cell-isolation-cell-separation-market
๐๐ผ๐ง ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐๐ถ๐ฐ๐ฒ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
๐ฅ๐ฒ๐๐ฝ๐ถ๐ฟ๐ฎ๐๐ผ๐ฟ๐ ๐๐ฎ๐ฟ๐ฒ ๐๐ฒ๐๐ถ๐ฐ๐ฒ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐: https://www.polarismarketresearch.com/industry-analysis/respiratory-care-devices-market
๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐๐ ๐ฐ๐ถ๐ฝ๐ถ๐ฒ๐ป๐๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ : https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market
๐ง๐ถ๐๐๐๐ฒ ๐๐ถ๐ฎ๐ด๐ป๐ผ๐๐๐ถ๐ฐ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ : https://www.polarismarketresearch.com/industry-analysis/tissue-diagnostics-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Market is projected to exhibit a CAGR of 4.7%, with an estimated worth of US$ 2.88 billion by year 2032 end | PMR here
News-ID: 3455200 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Colorectal
Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate โฆ
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685
This latest report researches theโฆ
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andโฆ
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @
https://goo.gl/1HQ4Fn .
Report Description:
Pharmaceutical guide Colorectal Cancer - Pipeline Review H1โฆ
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giantโs share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people dieโฆ
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always inโฆ
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the bodyโs digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, whichโฆ